Alerts will be sent to your verified email
Verify Email
DPL
|
Dipna Pharma.
|
Biofil Chem & Pharma
|
EVOQ Remedies
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
18.49 % | 5.35 % | 31.73 % |
|
5yr average Equity Multiplier
|
25.97 | 1.92 | 72.02 |
|
5yr Average Asset Turnover Ratio
|
1.53 | 0.98 | 1.09 |
|
5yr Avg Net Profit Margin
|
0.59 % | 2.92 % | 4.38 % |
|
Price to Book
|
0.0 | 6.68 | 0.0 |
|
P/E
|
24.65 | 176.75 | 9.36 |
|
5yr Avg Cash Conversion Cycle
|
34.12 Days | 95.25 Days | 400.27 Days |
|
Inventory Days
|
55.52 Days | 25.44 Days | 8.88 Days |
|
Days Receivable
|
101.37 Days | 168.17 Days | 381.41 Days |
|
Days Payable
|
111.64 Days | 169.49 Days | 159.27 Days |
|
5yr Average Interest Coverage Ratio
|
1.79 | 18.5 | 1477.2 |
|
5yr Avg ROCE
|
31.24 % | 7.83 % | 43.03 % |
|
5yr Avg Operating Profit Margin
|
2.18 % | 5.83 % | 6.0 % |
|
5 yr average Debt to Equity
|
11.61 | 0.06 | 0.21 |
|
5yr CAGR Net Profit
|
97.87 % | 3.13 % | 176.63 % |
|
5yr Average Return on Assets
|
1.01 % | 2.82 % | 3.47 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
9.98 % | 46.82 % | 20.53 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-56.58 % | 0.0 | -53.0 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Dipna Pharma.
|
Biofil Chem & Pharma
|
EVOQ Remedies
|
|
|---|---|---|---|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|
